Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.
- DOI
- 10.1016/j.critrevonc.2026.105619
- Published
- 2026 Sep 23
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2026.105619,
title = {Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.},
author = {Arrieta O and Caballé-Pérez E and Cabrera-Miranda L and Cardona AF and Davila-Dupont D and Velasco-Córdoba M and Treviño LAC},
year = {2026},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2026.105619},
url = {https://doi.org/10.1016/j.critrevonc.2026.105619}
}RIS
TY - JOUR TI - Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review. AU - Arrieta O AU - Caballé-Pérez E AU - Cabrera-Miranda L AU - Cardona AF AU - Davila-Dupont D AU - Velasco-Córdoba M AU - Treviño LAC PY - 2026 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2026.105619 UR - https://doi.org/10.1016/j.critrevonc.2026.105619 ER -
APA
O, A., E, C., L, C., AF, C., D, D., M, V., & LAC, T. (2026). Innovative Therapies for HER2-altered Non-Small Cell Lung Cancer: a Narrative Review.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105619
Source records
- pubmed · retrieved 2026-09-25T17:51:53.093Z